Stockreport

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Ventyx Biosciences, Inc.  (VTYX) 
PDF SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on advan [Read more]